Oramed Pharmaceuticals Inc.
ORMP
$3.65
$0.010.28%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 65.84M | 125.89M | 134.69M | 97.94M | 130.64M |
| Total Receivables | 450.00K | 5.09M | 402.00K | 611.00K | 208.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.86M | 2.29M | 1.03M | 475.00K | 624.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 68.15M | 133.27M | 136.12M | 99.03M | 131.48M |
|
|
|||||
| Total Current Assets | 68.15M | 133.27M | 136.12M | 99.03M | 131.48M |
| Net Property, Plant & Equipment | 1.25M | 1.34M | 1.43M | 1.53M | 1.01M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 471.00K | 599.00K | 1.09M | 4.52M | 5.52M |
| Total Assets | 268.85M | 230.86M | 220.49M | 161.68M | 147.54M |
|
|
|||||
| Total Accounts Payable | 481.00K | 443.00K | 560.00K | 715.00K | 509.00K |
| Total Accrued Expenses | 1.88M | 3.12M | 819.00K | 1.13M | 1.01M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 268.00K | 285.00K | 271.00K | 264.00K | 181.00K |
| Total Finance Division Other Current Liabilities | 7.93M | 15.23M | 4.47M | 1.58M | 3.79M |
| Total Other Current Liabilities | 7.93M | 15.23M | 4.47M | 1.58M | 3.79M |
| Total Current Liabilities | 10.56M | 19.09M | 6.12M | 3.69M | 5.49M |
|
|
|||||
| Total Current Liabilities | 10.56M | 19.09M | 6.12M | 3.69M | 5.49M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 493.00K | 540.00K | 589.00K | 648.00K | 120.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 19.52M | 11.49M | 11.46M | 3.76M | 2.03M |
| Total Liabilities | 30.57M | 31.12M | 18.16M | 8.10M | 7.65M |
|
|
|||||
| Common Stock & APIC | 323.40M | 323.18M | 325.86M | 325.50M | 325.07M |
| Retained Earnings | -85.12M | -123.44M | -122.58M | -170.97M | -184.26M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 238.28M | 199.74M | 203.28M | 154.53M | 140.81M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 238.28M | 199.74M | 203.28M | 154.53M | 140.81M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -952.00K | -946.00K | -918.00K |
| Total Equity | 238.28M | 199.74M | 202.33M | 153.58M | 139.89M |
|
|
|||||